My Account Login

ELIXIR MD™ Secures First and Only FDA Clearance For Soft Tissue Coagulation For LED Light Therapy in Plastic Surgery

IRVINE, CA, USA, July 28, 2024 /EINPresswire.com/ -- ELIXIR MD™, a global leader in photobiomodulation technology, has achieved a major milestone in the field of plastic surgery. The company is proud to announce that its revolutionary technology, (EPBM™), has received FDA 510(k) clearance for use in general and plastic surgery procedures. This makes ELIXIR MD™ the first and only company to receive such clearance for an LED light therapy device in the plastic surgery industry.

The FDA clearance is a significant achievement for ELIXIR MD™ and a testament to the safety and effectiveness of its EPBM™ technology. This clearance allows plastic surgeons to use ELIXIR MD™ device in a variety of procedures. The EPBM™ technology utilizes specific wavelengths of light to stimulate cellular activity, promoting healing and reducing inflammation, pain, and scarring.

"ELIXIR MD™ is committed to investing in R&D to provide plastic surgeons with the advancements they need to deliver the highest quality of care and achieve the fastest post-surgery results," said Ewan Yassen, CEO of ELIXIR MD™. "The new indication for soft tissue coagulation for LED light therapy in plastic surgery enhances the product's intended use, helping practitioners expand their patient base."

Since its inception, ELIXIR MD™ has been gaining widespread global brand awareness, with more than 70 plastic surgeons using the system worldwide. The ELIXIR MD™ brand is poised to become the new standard in plastic surgery for post-op recovery solutions.

About ELIXIR MD™

ELIXIR MD™ is at the forefront of medical innovation, dedicated to enhancing well-being and delivering impressive results. Specializing in Photobiomodulation Devices, our unique EPBM™ technology is designed to support Plastic Surgeons in enhancing surgical procedures and reducing recovery times. Our cutting-edge technology positions us strongly in the multi-billion dollar market, spanning various surgical specialties including plastic surgery and ENT. For more information about ELIXIR MD™ and its technology, visit www.elixir-md.com.

Michael Elias
ELIXIR MD™
+1 949-695-7727
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

View full experience

Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, Media, Advertising & PR, Technology